Comments on:

Pfizer: Long-acting Lyrica better than placebo

Back to the article » |
TRENTON, N.J. (AP) — Drugmaker Pfizer Inc. said Monday that a late-stage patient study found an extended-release version of its pain drug Lyrica relieved pain better than a dummy pill in some patients, but the improvement didn't last much longer. The study, funded by the New York-based drugmaker, is one of three late-stage patient tests aimed at gaining approval of Lyrica for another use, as a...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.